Company News

  • Snibe become the 1st in China who received FDA Cleared on CLIA product

    14th July 2017- Snibe Co., Ltd. receives the FDA clearance on the commercialization of TSH on MaglumiTM 2000 fully-automatic chemiluminescence immunoassay system. (US FDA 510 (k), K NO. : K162698) .It is the 1st company in China who received FDA cleared on CLIA product.
    Issue date:2017-10-27
  • 2019 Medica Invitation

    Issue date:2019-10-23
  • Snibe Shows Great Charms at 71th AACC

    Snibe brings the latest innovation MAGLUMI X8 to 71st AACC Annual Scientific Meeting & Clinical Lab Expo, with booth No. 1317 in California United States, one of the largest and most influential medical exhibitions across the world, attracting more than 21,000 visitors, and 800 exhibitors dedicated to sharing the most advanced technology available in the IVD, and medical laboratory market.
    Issue date:2019-08-13

New Product

More >>

About Us

To Be Global IVD Pioneer

Focus On Chemiluminescence Immunoassay For 24years

145Countries

12000Units

More
湖北快三 湖北快三 湖北快三 湖北11选5 湖北快三 湖北快三 湖北11选5 湖北11选5 湖北11选5 湖北11选5